Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression

A case report

Bibliographic Data

ID15527635
AuthorsLaurent Elkrief (0000-0002-2260-4433, Université de Montréal), Olivier Payette (Centre Hospitalier de l’Université de Montréal), Jean-Nicolas Foucault (Centre Hospitalier de l’Université de Montréal), Christophe Longpré-Poirier (0000-0003-1527-0874, Centre Hospitalier de l’Université de Montréal), Maxime Richard (0000-0001-7620-3814, Université de Montréal), Véronique Desbeaumes Jodoin (0000-0001-9784-942X, Centre Hospitalier de l’Université de Montréal), Paul Lespérance (0000-0001-9280-7925, Université de Montréal), Jean‐Philippe Miron (0000-0002-5277-541X, Centre Hospitalier de l’Université de Montréal, corresponding author), Jean-Philippe Miron
Year2022
Volume13
Pages986378-986378
Publication date2022-09-21
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2022.986378
PMID36213934
OpenAlexW4296745040
LanguageEN
References cited31

About a third of patients suffering from major depression develop treatment-resistant depression (TRD). Although repetitive transcranial magnetic stimulation (rTMS) and intravenous ketamine have proven effective for the management of TRD, many patients remain refractory to treatment. We present the case of a patient suffering from bipolar TRD. The patient was referred to us after failure to respond to first-and second-line pharmacotherapy and psychotherapy. After minimal response to both rTMS and ketamine alone, we attempted a combination rTMS and ketamine protocol, which led to complete and sustained remission. Various comparable and complimentary mechanisms of antidepressant action of ketamine and rTMS are discussed, which support further study of this combination therapy. Future research should focus on the feasibility, tolerability, and efficacy of this novel approach

Adverse effect · Anesthesia · Antidepressant · Anxiety · Deep brain stimulation · Depression (economics · Electroconvulsive therapy · Ketamine · Pharmacotherapy · Psychiatry · Psychotherapist · Refractory (planetary science · Schizophrenia (object-oriented programming · Stimulation · Tolerability · Transcranial magnetic stimulation · Treatment-resistant depression · Electroconvulsive Therapy Studies · Medicine · Psychology · Transcranial Magnetic Stimulation Studies · Treatment of Major Depression · Internal Medicine · Pharmacology

  • Large-Scale Network Dysfunction in Major Depressive Disorder

    Roselinde H Kaiser, Jessica R Andrews-Hanna et al.•JAMA Psychiatry•2015

  • Large-scale brain networks and psychopathology

    Open Access•Vinod Menon•Trends in Cognitive Sciences•2011

  • Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps

    A John Rush, Madhukar H Trivedi et al.•American Journal of Psychiatry•2006

  • A Retrospective Naturalistic Study Comparing the Efficacy of Ketamine and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression

    Open Access•Georgios Mikellides, Panayiota Michael et al.•Frontiers in Psychiatry•2022

  • The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication

    Open Access•Veronika Andrashko, Tomáš Novák et al.•Frontiers in Psychiatry•2020

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae